Biochem/physiol Actions
Cell permeable: no
Reversible: no
Product does not compete with ATP.
Primary TargetStimulator of interleukin-6 production by endothelial cell lines
General description
Attenuates thrombin-evoked aggregation of human platelets. A potent stimulator of interleukin-6 production by endothelial cell lines. Reported to activate phospholipase C in fibroblasts expressing ETA receptors.
Attenuates thrombin-evoked aggregation of human platelets. A potent stimulator of interleukin-6 production by endothelial cell lines. Reported to activate phopholipase C in fibroblasts expressing ETA receptors.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Gresser, O., et al. 1996. Biochem. Biophys. Res. Commun.224, 169.Astarie-Dequeker, C., et al. 1995. Br. J. Pharmacol. 114, 524.Xin, X., et al. 1995. Endocrinology 136, 132.Brunner, F., et al. 1992. J. Mol. Cell. Cardiol.24, 1291.Lamers, J.M., et al. 1992. Mol. Cell. Biochem. 116, 59.
Packaging
Yes
Physical form
Supplied as a trifluoroacetate salt. Sold on the basis of peptide content.
Preparation Note
Dissolve peptide initially at 8 mg/ml in 80% cold acetic acid, then dilute with cold water to 5% acetic acid and 0.5 mg/ml peptide.
Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
Sequence
H-Cys¹-Thr-Cys³-Phe-Thr-Tyr-Lys-Asp-Lys-Glu-Cys¹¹-Val-Tyr-Tyr-Cys¹⁵-His-Leu-Asp-Ile-Ile-Trp-OH (disulfide bonds: 1 → 15; 3 → 11)
This product has met the following criteria to qualify for the following awards: